Tel: +44(0)20 7691 0984 Email: Newsletter Sign Up
  • CEO Mark Duxon interviewed by The Pharma Letter on impact of Brexit on CROs...
  • Announcing new premises in Poland with a focus on neuropsychiatric disorders...
  • State-of-the-art premises opening this month at Discovery Park in Kent...
  • Newly published work in Frontiers in Psychiatry demonstrating
  • the effectiveness of a clinically relevant dose of ketamine...
  • Head to 2021 conferences page to see titles of abstracts...


All the latest conference updates; those that we are attending and the studies that we are presenting

19 to 23 October 2019 Chicago, USA

b2ap3 large sfn logoTranspharmation will again be attending the annual Society for Neuroscience meeting, which this year will be held in Chicago, USA. We'll have our largest ever team in attendance and will be proudly launching our new branding at booth 1810. We'll also be presenting a number of posters covering diverse research areas such as The NMDA Receptor Antagonist Ketamine Exerts Biphasic Effects on Mismatch Negativity in the Rat by Sandor Kantor.

Jack Prenderville, from our Irish facility, will also be co-organizing an Irish Neuroscience Gathering during SfN. This is an opportunity for Irish neuroscientists to meet and discuss the latest news and research developments over a drink in an Irish pub (of course!). If you would like more details please contact us.


Start a Conversation

uk flag+44 (0)20 7691 0984

ireland flag+353 (0)1896 42 60

poland flag+48 515 244 120



Copyright © 2021 Transpharmation Ltd. All Rights Reserved.

Copyright © 2019 Transpharmation Ltd. All Rights Reserved. Website created by Identity Ipswich Web Design